Perrigo Co PLC (PRGO): Operating Income
-$1.12B
Year ended 2025-12-31
-$1.56B
Trailing 12 months to 2026-06-27
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$1.12B | n/m | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $112.90M | -25.7% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $151.90M | +92.5% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $78.90M | -80.8% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $410.40M | +54.8% | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | $265.20M | +51.8% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $174.70M | n/c | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $236.50M | -60.5% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $598.20M | n/m | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | -$2.00B | n/a | 2019-02-27, From 2016-01-01 |
| No annual figure between 2015-06-27 and 2016-12-31. | |||
| 2015-06-27 | $672.50M | +17.7% | 2018-03-01, From 2014-06-29 |
| 2014-06-28 | $571.40M | -15.9% | 2017-05-22, From 2013-06-30 |
| 2013-06-29 | $679.10M | +19.3% | 2015-08-13, From 2012-07-01 |
| 2012-06-30 | $569.20M | n/a | 2014-08-14, From 2011-06-26 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Perrigo Co PLC (PRGO) | 2025-12-31 | -$1.12B | n/m |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | -$430.24M | n/m |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $501.58M | n/m |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $447.14M | n/m |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $409.48M | -15.4% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $1.49B | +8.4% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $394.10M | +58.1% |
| Royalty Pharma plc (RPRX) | 2025-12-31 | $1.56B | +20.7% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | -$699.78M | n/m |
Compare PRGO, JAZZ, ALNY, ONC side by side · Screen every company in Pharmaceutical Preparations ↗